Page last updated: 2024-09-04

pomalidomide and AIDS-Associated Lymphoma

pomalidomide has been researched along with AIDS-Associated Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ambinder, R; Cheever, M; Ekwede, I; George, J; Goncalves, PH; Gulley, JL; Lurain, K; Mangusan, R; Ramaswami, R; Uldrick, TS; Wang, HW; Widell, A; Yarchoan, R	1

Other Studies

1 other study(ies) available for pomalidomide and AIDS-Associated Lymphoma

Article	Year
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma. Journal for immunotherapy of cancer, 2021, Volume: 9, Issue:2 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; HIV Infections; Humans; Immune Checkpoint Inhibitors; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Thalidomide; Time Factors	2021

Article

Year

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma.

Journal for immunotherapy of cancer, 2021, Volume: 9, Issue:2

Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; HIV Infections; Humans; Immune Checkpoint Inhibitors; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Thalidomide; Time Factors

2021